# Adaptive Radiation Boost for Rectal Cancer

> **NCT07221058** · PHASE1 · RECRUITING · sponsor: **Fox Chase Cancer Center** · enrollment: 37 (estimated)

## Conditions studied

- Rectum Cancer, Adenocarcinoma

## Interventions

- **RADIATION:** Adaptive Radiotherapy Boost

## Key facts

- **NCT ID:** NCT07221058
- **Lead sponsor:** Fox Chase Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10-24
- **Primary completion:** 2028-11-01
- **Final completion:** 2029-11-01
- **Target enrollment:** 37 (ESTIMATED)
- **Last updated:** 2025-12-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07221058

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07221058, "Adaptive Radiation Boost for Rectal Cancer". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT07221058. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
